Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0140-2026

Boston Scientific Corporation recalls CX Preconnect with TENACIO Pump without InhibiZone

Boston Scientific CorporationMarlborough, MA, United StatesReported Oct 22, 2025 · 8 months ago
Legal News Analyst ·

Reason for recall

The potential for devices to experience inflation and/or deflation performance issues or difficulties.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

CX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404486 (15CM IP), (2) 72404488 (21CM IP);

Lot / code information

UDI
00191506021658
Lot #
1100676851, 1100676852; 2. UPN: 72404488 (21CM IP)
UDI
00191506021672
Lot #
1100717673

What the firm is doing

On September 11, 2025 URGENT MEDICAL DEVICE RECALL letters were sent to customers. Actions to be taken: For implanted devices: If the device is working properly, no action is required. Further evaluation is recommended for patients who were implanted with an affected device AND are having difficulty inflating or deflating the device. - Check inventory for affected product and return any unused devices. Immediately cease further distribution or use of any unused affected devices. Please pass this notice to any healthcare professional from your organization that needs to be aware and to any organization where the potentially affected devices have been transferred. Please provide Boston Scientific with details of any affected devices that have been transferred to another organization.

DistributionShow details

Worldwide distribution - US Nationwide and the country of Canada.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls